Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Rossari Biotech Limited has informed the Exchange regarding a press release dated Jun 02, 2021, titled "Rossari to acquire Unitop Chemicals ". Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Acquisition
Rossari Biotech Limited has agreed to acquire Unitop Chemicals Private Limited Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analysts/Institutional Investor Meet/Con. Call Update Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript
Intimation of Transcript of the Q4 FY2021 Earnings Conference Call held on May 17, 2021 Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Analysts/Institutional Investor Meet/Con. Call Updates Rossari Biotech Ltd - 543213 - Compliances-Reg.24(A)-Annual Secretarial Compliance
Annual Secretarial Compliance Report for the Financial Year 2020-21
Earnings Call for Q4FY21 of Rossari Biotech
Conference Call with Rossari Biotech Ltd. Management and Analysts on Q4FY21 Performance and Outlook. Listen to the full earnings transcript. Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Newspaper Publication
News Paper Publication of Extracts of Consolidated Audited Financial Results for the quarter and financial year ended March 31, 2021.
Rossari Biotech posts 37% revenue growth in Q4 at Rs 218 crore
Rossari Biotech has posted 37 per cent increase in its revenues from operations during the quarter ended March at Rs 218 crore as against Rs 160 crore in the year-ago period Rossari Biotech Ltd - 543213 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Intimation of Press Release titled " Rossari Biotech announces Q4 & FY21 results"